What it's for (Indications)
- Tobramycin + Dexamethasone ophthalmic drops, such as Eyebradex, are specifically indicated for the treatment of ocular inflammatory conditions for which a corticosteroid is indicated and where a superficial bacterial ocular infection or a risk of bacterial ocular infection exists.
- This combination therapy is particularly valuable in scenarios where both significant inflammation and potential or established bacterial presence warrant simultaneous intervention.
- Common indications include inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe, which are responsive to corticosteroids.
- This encompasses conditions such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis (but NOT herpes simplex keratitis due to steroid contraindications), iritis, cyclitis, and selected infective conjunctivitis when the inherent hazard of steroid use is accepted to obtain a diminution in edema and inflammation.
- Furthermore, these drops are frequently utilized in the post-operative management of ocular surgery, such as cataract extraction, to prevent and treat inflammation while providing prophylactic antibacterial coverage against common susceptible ocular pathogens.
- The dual action ensures comprehensive management by addressing both the inflammatory response and the potential for bacterial proliferation, thereby optimizing healing and patient outcomes.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For adults, the typical recommended dosage for Tobramycin + Dexamethasone ophthalmic drops is one or two drops instilled into the conjunctival sac of the affected eye(s) every four to six hours. For acute and severe ocular inflammatory or infectious conditions, the frequency of administration may be increased during the initial 24 to 48 hours, typically to one or two drops every two hours, until clinical improvement is observed. Subsequently, the frequency should be gradually reduced as the signs and symptoms of inflammation subside. It is crucial to adhere to the prescribed duration of therapy, which generally should not exceed 14 days, due to the potential risks associated with prolonged corticosteroid use, such as increased intraocular pressure and cataract formation. Patients should be instructed to shake the bottle well before each use and to avoid direct contact of the dropper tip with the eye or any other surface to prevent contamination of the solution. If other topical ophthalmic medications are being used concurrently, a minimum of five minutes should elapse between administrations to ensure proper absorption and efficacy of each product. Pediatric dosing should be determined by a healthcare professional based on specific clinical circumstances. |
Safety & Warnings
Common Side Effects
- As with any ophthalmic medication, Tobramycin + Dexamethasone drops can cause a range of side effects, although not all patients will experience them.
- Common ocular side effects include transient blurred vision immediately after instillation, ocular discomfort, burning or stinging sensation, itching, conjunctival hyperemia (redness), and eyelid edema or itching.
- Due to the dexamethasone component, prolonged use (typically beyond 10-14 days) can lead to more serious adverse effects, including elevated intraocular pressure (IOP) which may progress to glaucoma with optic nerve damage, defects in visual acuity and fields, and posterior subcapsular cataract formation.
- The corticosteroid component also carries a risk of secondary ocular infection, particularly fungal and viral infections (e.
- g.
- , exacerbation of herpes simplex keratitis), and delayed wound healing.
- Tobramycin, as an aminoglycoside antibiotic, can cause localized hypersensitivity reactions in some individuals, manifesting as eyelid itching, edema, conjunctival erythema, and even generalized rash.
- Less common but severe reactions may include corneal thinning or perforation in patients with pre-existing corneal diseases.
- Systemic absorption is generally minimal, but potential systemic corticosteroid effects should be considered with prolonged or excessive use.
Serious Warnings
- Black Box Warning: None
- Several critical warnings are associated with the use of Tobramycin + Dexamethasone ophthalmic drops.
- Firstly, **Increased Intraocular Pressure (IOP)**: Prolonged use of corticosteroids, even topically, can lead to elevated IOP, potentially resulting in glaucoma with optic nerve damage, visual field defects, and posterior subcapsular cataract formation.
- Regular monitoring of IOP is essential for patients receiving prolonged therapy, especially those with a history of glaucoma or a predisposition to elevated IOP.
- Secondly, **Secondary Ocular Infection**: Corticosteroids can mask the signs of infection and suppress the host immune response, increasing susceptibility to secondary ocular infections, particularly fungal and viral infections, such as herpes simplex keratitis.
- Use in patients with active herpes simplex keratitis is generally contraindicated.
- Fungal infection should be suspected in any persistent corneal ulceration where a corticosteroid has been used.
- Thirdly, **Corneal/Scleral Thinning**: In conditions causing thinning of the cornea or sclera, the use of topical corticosteroids may lead to perforation.
- Fourthly, **Hypersensitivity Reactions**: Tobramycin can cause allergic reactions, which may manifest as itching, eyelid swelling, and conjunctival erythema.
- Discontinue use if hypersensitivity develops.
- Fifthly, **Contact Lenses**: Patients should be advised not to wear contact lenses during treatment due to the risk of absorption of preservatives and potential exacerbation of ocular irritation or infection.
- Lastly, temporary blurred vision or other visual disturbances may affect the ability to drive or operate machinery immediately after instillation; patients should be advised to exercise caution until their vision is clear.
How it Works (Mechanism of Action)
The therapeutic efficacy of Tobramycin + Dexamethasone ophthalmic drops stems from the synergistic actions of its two active components. **Tobramycin** is a broad-spectrum aminoglycoside antibiotic that exerts its bactericidal effect by irreversibly binding to the 30S ribosomal subunit of susceptible bacteria. This binding interferes with bacterial protein synthesis, leading to the production of non-functional proteins and ultimately causing cell death. Tobramycin is highly effective against a wide range of Gram-negative bacteria, including problematic strains like Pseudomonas aeruginosa, and also demonstrates activity against certain Gram-positive organisms, such as Staphylococcus aureus and Staphylococcus epidermidis, which are common ocular pathogens. **Dexamethasone** is a potent synthetic corticosteroid known for its anti-inflammatory and immunosuppressive properties. It functions by diffusing across cell membranes and binding to specific cytoplasmic receptors. The resulting steroid-receptor complex then translocates to the cell nucleus, where it binds to specific DNA sequences (glucocorticoid response elements). This binding modulates gene expression, leading to the synthesis of anti-inflammatory proteins (e.g., lipocortins) and the inhibition of pro-inflammatory mediators such (e.g., prostaglandins, leukotrienes). Dexamethasone effectively reduces inflammation, edema, fibrin deposition, capillary dilation, leukocyte migration, and collagen formation, thereby alleviating ocular discomfort, redness, and swelling. The combination provides comprehensive management by simultaneously targeting bacterial infection and mitigating the associated inflammatory response, which is crucial for optimal healing and preventing tissue damage in the eye.
Commercial Brands (Alternatives)
No other brands found for this formula.